AHR/NRF2 Dual Agonist Prediction and Natural Compound Screening Based on Machine Learning: A New Strategy for the Treatment of Atopic Dermatitis.

Int J Mol Sci · 2026 · PMC13115769 · PMID 42074173

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a numerical trendno p-value reported

Although bergapten was not significant, it still showed a numerical trend of activating AHR and NRF2, and is a potential dual agonist.

also in 708 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.